Section of Endocrine Surgery, Department of Surgery, University of Wisconsin, Madison, WI 53792, USA.
Ann Surg. 2013 Jan;257(1):138-41. doi: 10.1097/SLA.0b013e31825ffbe1.
The aim of our study was to create a preoperative "index" that could predict the likelihood of additional hyperfunctioning parathyroid glands and let the surgeon determine whether to wait for the intraoperative parathyroid hormone (ioPTH) or to explore further.
During parathyroidectomy for primary hyperparathyroidism (PHPT), discovering a minimally "enlarged" parathyroid gland creates a dilemma for the surgeon regarding the need for further exploration. Although ioPTH testing can potentially solve this problem after a 20- to 30-minute period, several surgeons recognize that further operative exploration may be more effective.
We analyzed a prospective database of 1235 consecutive patients who underwent parathyroidectomy for PHPT at our institution between March 2001 and August 2010. The Wisconsin Index (WIN) was defined as the multiplication of preoperative serum calcium by preoperative parathyroid hormone (PTH). Patients were divided into 3 WIN categories: low (<800), medium (801-1600), and high (>1600). The utility of the WIN was then validated on a subsequent cohort of 216 patients.
The median age of the patients was 61 years (range, 10-91), and 77% of the patients were female. The mean preoperative calcium and PTH levels were 11.0 ± 0 mg/dL and 127 ± 3 pg/mL, respectively. The mean WIN for the entire cohort was 1461 ± 38 and highly correlated with gland weight (P < 0.000001). A single adenoma was identified in 1000 patients (81%), double adenoma in 100 patients (8%), and hyperplasia in 135 patients (11%). The mean gland weights for the 3 WIN catagories were low = 370 ± 33 mg, medium = 532 ± 39 mg, and high = 985 ± 28 mg, respectively (P < 0.000001). A WIN nomogram, consisting of the combination of WIN and parathyroid gland weight, accurately predicted the likelihood of additional hyperfunctioning parathyroid glands. For example, for a WIN of less than 800 and a gland weight of 500 mg, there is a 9% chance for additional hyperfunctioning parathyroid glands based on the WIN nomogram. In contrast, for the same gland weight, if the WIN is 801 to 1600, these chances increase to 28%, and if the WIN is more than 1600, the chance of multigland disease is 61%. Comparison between the predicted chances for another gland with the actual chance in the validation cohort identified an R(2) value of 0.96.
The WIN nomogram predicts the likelihood of additional hyperfunctioning parathyroid glands during parathyroidectomy. This simple intraoperative tool may be used to guide the decision of whether to wait for ioPTH results or to proceed with further neck exploration.
本研究旨在创建一个术前“指数”,以预测额外功能性甲状旁腺的可能性,并让外科医生决定是否等待术中甲状旁腺激素(ioPTH)检测,或进一步探查。
在原发性甲状旁腺功能亢进症(PHPT)的甲状旁腺切除术期间,发现一个最小程度“增大”的甲状旁腺会给外科医生带来是否需要进一步探查的困境。尽管 ioPTH 检测在 20-30 分钟后可能会解决这个问题,但一些外科医生认为进一步的手术探查可能更有效。
我们分析了 2001 年 3 月至 2010 年 8 月期间在我院接受 PHPT 甲状旁腺切除术的 1235 例连续患者的前瞻性数据库。威斯康星州指数(WIN)定义为术前血清钙乘以术前甲状旁腺激素(PTH)。患者分为 3 个 WIN 类别:低(<800)、中(801-1600)和高(>1600)。然后在随后的 216 例患者队列中验证了 WIN 的有效性。
患者的中位年龄为 61 岁(范围,10-91),77%的患者为女性。术前钙和 PTH 水平的平均值分别为 11.0±0mg/dL 和 127±3pg/mL。整个队列的平均 WIN 为 1461±38,与腺体重量高度相关(P<0.000001)。1000 例患者(81%)中发现单个腺瘤,100 例患者(8%)中发现双腺瘤,135 例患者(11%)中发现增生。3 个 WIN 类别中的平均腺体重量分别为低=370±33mg、中=532±39mg、高=985±28mg(P<0.000001)。一个由 WIN 和甲状旁腺重量组合而成的 WIN 列线图,准确地预测了额外功能性甲状旁腺的可能性。例如,对于 WIN 小于 800 和腺体重量为 500mg 的情况,根据 WIN 列线图,额外功能性甲状旁腺的可能性为 9%。相比之下,对于相同的腺体重量,如果 WIN 为 801-1600,则这些可能性增加到 28%,如果 WIN 大于 1600,则多腺体疾病的可能性为 61%。将预测的另一个腺体的可能性与验证队列中的实际可能性进行比较,确定 R(2)值为 0.96。
WIN 列线图预测甲状旁腺切除术期间额外功能性甲状旁腺的可能性。这个简单的术中工具可以用来指导是否等待 ioPTH 结果或进一步探查颈部的决策。